10-K/A
Index to Financial Statements
0.5P10D0001820727--12-31FYtrueNY 0001820727 2020-12-31 0001820727 2021-12-31 0001820727 2020-07-30 2020-12-31 0001820727 2021-01-01 2021-12-31 0001820727 2020-12-14 0001820727 2020-12-07 0001820727 2020-01-01 2020-12-31 0001820727 2020-07-30 2020-07-30 0001820727 2021-06-30 0001820727 2021-04-01 0001820727 2020-07-29 0001820727 muds:PublicWarrantsMember 2021-01-01 2021-12-31 0001820727 muds:AdministrativeSupportAgreementMember 2021-01-01 2021-12-31 0001820727 muds:SponsorMember us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001820727 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001820727 us-gaap:IPOMember muds:SponsorMember 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-01-01 2021-12-31 0001820727 us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-01-01 2021-12-31 0001820727 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-01-01 2021-12-31 0001820727 us-gaap:CommonClassBMember 2021-01-01 2021-12-31 0001820727 us-gaap:CommonClassAMember 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001820727 muds:UnitsEachConsistingOfOneShareOfClassCommonStockAndOneHalfOfOneWarrantMember 2021-01-01 2021-12-31 0001820727 muds:WarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceMember 2021-01-01 2021-12-31 0001820727 muds:SponsorMember muds:AdministrativeSupportAgreementMember 2021-01-01 2021-12-31 0001820727 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001820727 us-gaap:USTreasurySecuritiesMember 2020-12-31 0001820727 us-gaap:CommonClassBMember 2020-12-31 0001820727 us-gaap:CommonClassAMember 2020-12-31 0001820727 muds:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-12-31 0001820727 muds:RelatedPartyLoansMember muds:WorkingCapitalLoansWarrantMember 2020-12-31 0001820727 us-gaap:OverAllotmentOptionMember us-gaap:CommonClassBMember 2020-12-31 0001820727 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001820727 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001820727 muds:PublicWarrantsMember 2020-12-31 0001820727 muds:PrivatePlacementWarrantsMemberMember 2020-12-31 0001820727 muds:WorkingCapitalLoansWarrantMember muds:UnsecuredConvertiblePromissoryNoteWithRelatedPartyMember 2020-12-31 0001820727 muds:AdministrativeSupportAgreementMember muds:SponsorMember 2020-01-01 2020-12-31 0001820727 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-12-10 2020-12-10 0001820727 us-gaap:IPOMember 2020-12-10 2020-12-10 0001820727 muds:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-12-10 2020-12-10 0001820727 muds:PrivatePlacementWarrantsMember us-gaap:PrivatePlacementMember 2020-12-10 0001820727 muds:SponsorMember us-gaap:PrivatePlacementMember 2020-12-10 0001820727 us-gaap:PrivatePlacementMember 2020-12-10 0001820727 us-gaap:IPOMember 2020-12-10 0001820727 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-12-10 0001820727 us-gaap:OverAllotmentOptionMember 2020-12-14 2020-12-14 0001820727 us-gaap:IPOMember muds:PublicWarrantsMember 2020-12-14 2020-12-14 0001820727 us-gaap:IPOMember 2020-12-14 2020-12-14 0001820727 us-gaap:PrivatePlacementMember 2020-12-14 0001820727 us-gaap:OverAllotmentOptionMember muds:PrivatePlacementWarrantsMember 2020-12-14 0001820727 us-gaap:IPOMember 2020-12-14 0001820727 us-gaap:IPOMember muds:PublicWarrantsMember 2020-12-14 0001820727 us-gaap:CommonClassBMember 2021-12-31 0001820727 us-gaap:CommonClassAMember 2021-12-31 0001820727 muds:UnsecuredConvertiblePromissoryNoteWithRelatedPartyMemberMember 2021-12-31 0001820727 us-gaap:IPOMember 2021-12-31 0001820727 muds:PublicWarrantsMember 2021-12-31 0001820727 muds:WorkingCapitalLoansWarrantMember muds:SponsorMember 2021-12-31 0001820727 muds:SponsorMember us-gaap:IPOMember 2021-12-31 0001820727 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001820727 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001820727 muds:PrivatePlacementWarrantsMemberMember 2021-12-31 0001820727 us-gaap:MoneyMarketFundsMember 2021-12-31 0001820727 muds:UnsecuredConvertiblePromissoryNoteWithRelatedPartyMember muds:WorkingCapitalLoansWarrantMember 2021-12-31 0001820727 muds:SponsorMember us-gaap:CommonClassBMember 2020-08-03 2020-08-03 0001820727 muds:AdministrativeSupportAgreementMember 2020-12-07 2020-12-07 0001820727 us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2020-12-31 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2020-12-31 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2020-12-31 2020-12-31 0001820727 us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2020-12-31 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2020-12-31 2020-12-31 0001820727 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2020-12-31 2020-12-31 0001820727 us-gaap:AdditionalPaidInCapitalMember 2020-07-30 2020-12-31 0001820727 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-07-30 2020-12-31 0001820727 us-gaap:CommonClassBMember 2020-07-30 2020-12-31 0001820727 muds:AdministrativeSupportAgreementMember 2020-07-30 2020-12-31 0001820727 us-gaap:RetainedEarningsMember 2020-07-30 2020-12-31 0001820727 muds:PublicWarrantsMember 2020-07-30 2020-12-31 0001820727 muds:SponsorMember us-gaap:CommonClassBMember 2020-07-30 2020-12-31 0001820727 us-gaap:CommonClassAMember 2020-07-30 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member 2020-07-30 2020-12-31 0001820727 muds:SponsorMember muds:UnsecuredConvertiblePromissoryNoteWithRelatedPartyMemberMember 2021-11-22 0001820727 muds:SponsorMember us-gaap:CommonClassBMember 2020-11-30 0001820727 us-gaap:CommonClassAMember 2022-03-29 0001820727 us-gaap:CommonClassBMember 2022-03-29 0001820727 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001820727 us-gaap:RetainedEarningsMember 2021-12-31 0001820727 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001820727 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001820727 us-gaap:FairValueInputsLevel3Member 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001820727 us-gaap:RetainedEarningsMember 2020-07-29 0001820727 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-07-29 0001820727 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2020-07-29 0001820727 us-gaap:RetainedEarningsMember 2020-12-31 0001820727 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001820727 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001820727 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001820727 us-gaap:FairValueInputsLevel3Member 2020-07-29 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Month utr:Year iso4217:USD xbrli:shares muds:item muds:Vote
Table of Contents
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-K/A
Amendment No. 1
 
 
 
☒
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2021
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
    
    
    
    
to
                    
Commission file number: 001-39771
 
 
MUDRICK CAPITAL ACQUISITION CORPORATION II
(Exact name of registrant as specified in its charter)
 
 
 
Delaware
  
85-2320197
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification Number)
   
527 Madison Avenue, 6th Floor
New York, New York
  
10022
(Address of principal executive offices)
  
(Zip Code)
Registrant’s telephone number, including area code: (646)
747-9500
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class:
  
Trading
Symbol(s)
  
Name of Each Exchange
on Which Registered:
Units, each consisting of one share of Class A Common Stock and one-half of one Redeemable Warrant
  
MUDSU
  
The Nasdaq Stock Market LLC
Class A Common Stock, par value $0.0001 per share
  
MUDS
  
The Nasdaq Stock Market LLC
Warrants, each exercisable for one share
Class A Common Stock for $11.50 per share
  
MUDSW
  
The Nasdaq Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act: None
 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes  ☐    No  ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act.    Yes  ☐    No  ☒
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer, “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated filer   ☒    Smaller reporting company   ☒
       
Emerging growth company   ☒         
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☒    No  ☐
At June 30, 2021, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the registrant’s Class A common stock outstanding, other than shares held by persons who may be deemed affiliates of the registrant, at June 30, 2021, computed by reference to the closing price for the Class A common stock on such date, as reported on the Nasdaq Stock Market, was $394,047,500.
As of March 29, 2022, there we
re 31,625,000 
shares of Class A common stock, par value $0.0001 per share and
 7,906,250 
shares of Class B common stock, par value $0.0001 per share, of the registrant issued and outstanding.
 
 
 
 
EXPLANATORY NOTE
This Amendment No. 1 (the “
Amendment No. 1
”) to the Annual Report on Form 10-K of Mudrick Capital Acquisition Corporation II (the “
Company
”) for the period ended December 31, 2021, originally filed with the Securities and Exchange Commission on March 29, 2022, is being filed solely to correct a typographical error with the issue date of the report provided by the Company’s independent auditor WithumSmith+Brown, PC. Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, we have repeated the entire text of Item 8 of the Form 10-K in this Amendment No. 1. However, there have been no changes to the text of such item other than the change in the date of the auditor’s report.
In addition, the Company is including in this Amendment No. 1 currently dated certifications from its Chief Executive Officer and Chief Financial Officer as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 as Exhibits 31.1 and 31.2 and Exhibits 32.1 and 32.2, respectively.
Except as expressly set forth above, this Amendment No. 1 speaks as of the original filing date of the Form 10-K, and does not reflect events that may have occurred subsequent to that date, nor does it modify or update in any way disclosure made in the original Form 10-K.

TABLE OF CONTENTS
 
 
  
PAGE
 
Item 8.
 
  
 
2
 
Item 15.
 
  
 
3
 
Item 16.
 
  
 
3
 
 
1
PART II
 
Item 8.
Financial Statements and Supplementary Data
This information appears following Item 16 of this Amendment No. 1 to the Annual Report on Form 10-K and is included herein by reference.
 
2
PART IV
 
Item 15.
Exhibits, Financial Statements and Financial Statement Schedules
 
 
(a)
The following documents are filed as part of this Amendment No. 1 to the Annual Report on Form 10-K:
 
 
1.
Financial Statements
 
Report of Independent Registered Public Accounting Firm
  
 
F-2
 
Financial Statements:
  
Balance Sheet
  
 
F-3
 
Statement of Operations
  
 
F-4
 
Statement of Changes in Stockholders’ Equity
  
 
F-5
 
Statement of Cash Flows
  
 
F-6
 
Notes to Financial Statements
  
 
F-7
 
 
 
2.
Financial Statements Schedule
All financial statement schedules are omitted because they are not applicable or the amounts are immaterial and not required, or the required information is presented in the financial statements and notes thereto beginning on page F-1 of this Amendment No. 1 to the Annual Report on Form 10-K.
 
 
3.
Exhibits
We hereby file as part of this report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference are available on the SEC website at www.sec.gov.
 
Item 16.
Form 10-K Summary
Not applicable.
 
3
Table of Contents
 
MUDRICK CAPITAL ACQUISITION CORPORATION II
INDEX TO FINANCIAL STATEMENTS
 
  
 
F-2
 
Consolidated Financial Statements:
  
  
 
F-3
 
  
 
F-4
 
  
 
F-5
 
  
 
F-6
 
  
 
F-7
 
 
F-1
 
Report of Independent Registered Public Accounting Firm
To the Stockholders and the Board of Directors of
Mudrick Capital Acquisition Corporation II
Opinion on the Financial Statements
We have audited the accompanying balance sheets of Mudrick Capital Acquisition Corporation II (the “Company”) as of December 31, 2021 and 2020 the related statement of operation, changes in stockholder’s equity and cash flows for the year ended December 31, 2021 and the period from July 30, 2020 (inception) through December 31, 2020 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020 the related statement of operation, changes in stockholder’s equity and cash flows for the year ended December 31, 2021 and the period from July 30, 2020 (inception) through December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.
Going Concern
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the financial statements, if the Company is unable to raise additional funds to alleviate liquidity needs and complete a business combination by September 10, 2022 then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provide a reasonable basis for our opinion.
/s/ WithumSmith+Brown, PC
We have served as the Company’s auditor since 2020.
New York, New York
March 29, 202
2
PCAOB ID Number
100
 
F-2
MUDRICK CAPITAL ACQUISITION CORPORATION II
CONSOLIDATED BALANCE SHEETS
                 
    
December 31,

2021
    
December 31,

2020
  
              
ASSETS
                 
Current assets
                 
Cash
    $ 138,686     $ 1,117,679  
Prepaid expenses
      82,708       167,708  
    
 
 
    
 
 
  
Total Current Assets
      221,394       1,285,387  
Investments held in Trust Account
      321,039,924       321,002,166  
    
 
 
    
 
 
  
TOTAL ASSETS
   
$
321,261,318
 
  
$
322,287,553
 
    
 
 
    
 
 
  
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
                 
Current liabilities
                 
Accrued expenses
    $ 5,044,473     $ 102,348  
    
 
 
    
 
 
  
Total Current Liabilities
      5,044,473       102,348  
Convertible note – related party
      1,000,000       —
 
 
  
Warrant liabilities
      22,097,338       24,560,101  
Deferred underwriting fee payable
      11,068,750       11,068,750  
    
 
 
    
 
 
  
TOTAL LIABILITIES
   
 
39,210,561
 
  
 
35,731,199
 
    
 
 
    
 
 
  
Commitments and Contingencies
                 
Class A common stock subject to possible redemption 31,625,000 shares at approximately $10.15 per share as of December 31, 2021, and 2020
      320,993,750       320,993,750  
Stockholders’ Deficit
                 
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding
      —         —    
Class A common stock, $0.0001 par value; 100,000,000 shares authorized
      —         —    
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 7,906,250 shares issued and outstanding, as of December 31, 2021, and 2020
      791       791  
Additional
paid-in
capital
      —         —    
Accumulated deficit
      (38,943,784 )      (34,438,187 ) 
    
 
 
    
 
 
  
Total Stockholders’ Deficit
   
 
(38,942,993
) 
  
 
(34,437,396
) 
    
 
 
    
 
 
  
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT
   
$
321,261,318
 
  
$
322,287,553
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-3
MUDRICK CAPITAL ACQUISITION CORPORATION II
CONSOLIDATED STATEMENTS OF OPERATIONS
                 
    
Year Ended
December 31,
2021
    
For the Period
from July 30,
2020
(Inception)
through
December 31,
2020
  
              
General and administrative expenses
    $ 7,041,226     $ 110,911  
    
 
 
    
 
 
  
Loss from operations
   
 
(7,041,226
) 
  
 
(110,911
) 
Other income (expense):
                 
Interest earned on investments held in Trust Account
      72,866       8,416  
Change in fair value of warrant liabilities
      2,462,763       (938,033 ) 
Transaction costs
      —         (696,870 ) 
    
 
 
    
 
 
  
Total other income (expense), net
      2,535,629       (1,626,487 ) 
    
 
 
    
 
 
  
Net loss
   
$
(4,505,597
) 
  
$
(1,737,398
) 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class A common stock
      31,625,000       4,317,500  
    
 
 
    
 
 
  
Basic and diluted net loss per share, Class A common stock
   
$
(0.11
) 
  
$
(0.14
) 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class B common stock
      7,906,250       7,835,208  
    
 
 
    
 
 
  
Basic and diluted net loss per share, Class B common stock
   
$
(0.11
) 
  
$
(0.14
) 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-4
Table of Contents
MUDRICK CAPITAL ACQUISITION CORPORATION II
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT
                                                         
    
Class A

Common Stock
     
Class B

Common Stock
     
Additional
Paid-in
    
Accumulated
    
Total
Stockholders’
  
                                                
    
Shares
     
Amount
     
Shares
     
Amount
     
Capital
    
Deficit
    
Deficit
  
                                                
Balance – July 30, 2020 (Inception)
   
 
—  
 
   
$
—  
 
   
 
—  
 
   
$
—  
 
   
$
—  
 
  
$
—  
 
  
$
—  
 
Issuance of Class B common stock to Sponsor
      —          —          7,906,250        791        24,209       —         25,000  
Sale of Private Placement Warrants (Proceeds received in excess of fair value)
      —          —          —          —          1,233,398       —         1,233,398  
Accretion for Class A common stock to redemption amount
      —          —          —          —          (1,257,607 )      (32,700,789 )      (33,958,396 ) 
Net loss
      —          —          —          —          —         (1,737,398 )      (1,737,398 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance – December 31, 2020
   
 
—  
 
   
$
—  
 
   
 
7,906,250
 
   
$
791
 
   
$
—  
 
  
$
(34,438,187
) 
  
$
(34,437,396
) 
Net loss
      —          —          —          —          —         (4,505,597 )      (4,505,597 ) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
Balance – December 31, 2021
   
 
—  
 
   
$
—  
 
   
 
7,906,250
 
   
$
791
 
   
$
—  
 
  
$
(38,943,784
) 
  
$
(38,942,993
) 
    
 
 
     
 
 
     
 
 
     
 
 
     
 
 
    
 
 
    
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-5
Table of Contents
MUDRICK CAPITAL ACQUISITION CORPORATION II
CONSOLIDATED STATEMENTS OF CASH FLOWS
                 
    
Year

Ended

December 31,
2021
    
For the

Period from

July 30,

2020 (Inception)

Through

December 31,
2020
  
              
Cash Flows from Operating Activities:
                 
Net loss
    $ (4,505,597 )    $ (1,737,398 ) 
Adjustments to reconcile net loss to net cash used in operating activities:
                 
Payment of formation costs through promissory note – related party
      —         1,250  
Change in fair value of warrant liabilities
      (2,462,763 )      938,033  
Transaction costs allocated to warrants
      —         696,870  
Interest earned on investments held in Trust Account
      (72,866 )      (8,416 ) 
Changes in operating assets and liabilities:
                 
Prepaid expenses
      85,000       (167,708 ) 
Accrued expenses
      4,942,125       102,348  
    
 
 
    
 
 
  
Net cash used in operating activities
   
 
(2,014,101
) 
  
 
(175,021
) 
    
 
 
    
 
 
  
Cash Flows from Investing Activities:
                 
Investment of cash in Trust Account
      —         (320,993,750 ) 
Cash withdrawn from Trust Account to pay franchise and income taxes
      35,108       —    
    
 
 
    
 
 
  
Net cash provided by (used in) investing activities
   
 
35,108
 
  
 
(320,993,750
) 
Cash Flows from Financing Activities:
                 
Proceeds from sale of Units, net of underwriting discounts paid
      —         309,925,000  
Proceeds from sale of Private Placement Warrants
      —         12,818,750  
Proceeds from promissory note – related party
      —       —    
Repayment of promissory note – related party
      —       (135,680 ) 
Payment of offering costs
      —         (321,620 ) 
Advances from related party
      33,816       —    
Repayment of advances from related party
      (33,816 )      —    
Proceeds from convertible note – related party
      1,000,000       —    
    
 
 
    
 
 
  
Net cash provided by financing activities
   
 
1,000,000
 
  
 
322,286,450
 
    
 
 
    
 
 
  
Net Change in Cash
   
 
(978,993
) 
  
 
1,117,679
 
Cash – Beginning of period
      1,117,679       —    
    
 
 
    
 
 
  
Cash – End of period
   
$
138,686
 
  
$
1,117,679
 
    
 
 
    
 
 
  
Supplemental disclosure of
non-cash
 
investing and financing activities:
                 
Offering costs paid through promissory note – related party
    $ —       $ 134,430  
    
 
 
    
 
 
  
Offering costs paid directly by Sponsor in consideration for the issuance of Class B common stock
    $ —       $ 25,000  
    
 
 
    
 
 
  
Deferred underwriting fee payable
    $ —       $ 11,068,750  
    
 
 
    
 
 
  
The accompanying notes are an integral part of the consolidated financial statements.
 
F-6
Table of Contents
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Mudrick Capital Acquisition Corporation II (the “
Company
”) is a blank check company incorporated in Delaware on July 30, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “
Business Combination
”).
The Company has two wholly owned subsidiaries which were formed on April 1, 2021, Titan Merger Sub I, Inc., a Delaware corporation and Titan Merger Sub II, LLC, a Delaware limited liability company.
The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of December 31, 2021, the Company had not commenced any operations. All activity through December 31, 2021, relates to the Company’s formation, initial public offering (“
Initial Public Offering
”), which is described below, and identifying a target company for a Business Combination and activities in connection with the announced and subsequently terminated acquisition of Topps Intermediate Holdco, Inc. (“
Topps
”), a Delaware corporation (as described below). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.
On April 6, 2021, the Company entered into an Agreement and Plan of Merger (the “
Merger Agreement
”) and related agreements with Topps. Pursuant to the Merger Agreement, the Company agreed to acquire all the outstanding capital stock of Topps (the “
Topps Merger
”). On August 20, 2021, the parties terminated the Topps Merger, effective August 20, 2021.
The registration statement for the Company’s Initial Public Offering was declared effective on December 7, 2020. On December 10, 2020, the Company consummated the Initial Public Offering of 27,500,000 units (the “
Units
” and, with respect to the Class A common stock included in the Units sold, the “
Public Shares
”), at $10.00 per Unit, generating gross proceeds of $275,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 10,000,000 warrants (the “
Sponsor Private Placement Warrants
”) at a price of $1.00 per Private Placement Warrant in a private placement to Mudrick Capital Acquisition Holdings II LLC (the “
Sponsor
”) and the sale of 1,375,000 warrants (the “
Jefferies Private Placement Warrants
” and together with the Sponsor Private Placement Warrants, the “
Private Placement Warrants
”) at a price of $1.00 per Private Placement Warrant in a private placement to Jefferies LLC (“Jefferies”), generating gross proceeds of $11,375,000 which is described in Note 4.
On December 14, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 4,125,000 Units issued for an aggregate amount of $41,250,000. In connection with the underwriters’ full exercise of their over-allotment option, the Company also consummated the sale of an additional 1,443,750 Private Placement Warrants at $1.00 per Private Placement Warrant, generating total proceeds of $1,443,750.
Transaction costs amounted to $17,874,801, consisting of $6,325,000 in cash underwriting fees, $11,068,750 of deferred underwriting fees and $481,051 of other offering costs.
Following the closing of the Initial Public Offering on December 10, 2020, and the underwriters’ full exercise of their over-allotment option on December 14, 2020, an amount of $320,993,750 ($10.15 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “
Trust Account
”), located in the United States and invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “
Investment Company Act
”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.
 
 
F-7
Table of Contents
 
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into a Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act.
The Company will provide the holders of the outstanding Public Shares (the “
Public Stockholders
”) with the opportunity to convert all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Stockholders will be entitled to convert their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.15 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.
The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “
Certificate of Incorporation
”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“
SEC
”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Stockholder may elect to convert their Public Shares without voting, and if they do vote, irrespective of whether they vote for or against the proposed transaction.
Notwithstanding the foregoing, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Certificate of Incorporation provides that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “
Exchange Act
”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the Public Shares, without the prior consent of the Company.
The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Certificate of Incorporation (i) to modify the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other material provisions relating to stockholders’ rights or
pre-business
combination activity, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.
 
F-8
Table of Contents
The Company has until September 10, 2022, to complete a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to pay taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The Sponsor has agreed to waive its liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the amount of funds deposited into the Trust Account ($10.15 per share).
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.15 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.15 per public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity and Going Concern
As of December 31, 2021, the Company had approximately $138,686 in its operating bank accounts and working capital deficit of $4,776,905.
Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through a contribution of $25,000 from Sponsor to cover for certain offering costs in exchange for the issuance of the Founder Shares, the loan of up to $300,000 from the Sponsor pursuant to the Note (see Note 5), and the proceeds from the consummation of the Private Placement not held in the Trust Account. The Note was repaid on December 10, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5).
There were $1,000,000 and no amounts outstanding under any Working Capital Loan as of December 31, 2021 and 2020, respectively.
 
F-9
 
The Company may raise additional capital through loans or additional investments from the Sponsor or its stockholders, officers, directors, or third parties. The Company’s officers and directors and the Sponsor may, but are not obligated to, loan the Company funds, from time to time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, suspending the pursuit of a Business Combination. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all.
In connection with the Company’s assessment of going concern considerations in accordance with FASB’s Accounting Standards Update (“ASU”)
2014-15,
“Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined the liquidity condition and date for mandatory liquidation and dissolution raise substantial doubt about the Company’s ability to continue as a going concern through September 10, 2022, the scheduled liquidation date of the Company if it does not complete a Business Combination prior to such date. Management of the Company plans to complete a business combination prior to the date for mandatory liquidation. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“
U.S. GAAP
”) and pursuant to the accounting and disclosure rules and regulations of the SEC.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of the Company and its majority owned subsidiary where the Company has the ability to exercise control. All significant intercompany balances and transactions have been eliminated in consolidation. Activities in relation to the noncontrolling interest are not considered to be significant and are, therefore, not presented in the accompanying consolidated financial statements.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
 
F-10
Table of Contents
Use of Estimates
The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2021, and 2020.
Class A Common Stock Subject to Possible Redemption
The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity” (“ASC 480”). Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable Class A common stock (including Class A common stock that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, Class A common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, shares of Class A common stock subject to possible redemption are presented as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.
Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount value. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.
At December 31, 2021 and 2020, the Class A common stock reflected in the consolidated balance sheets are reconciled in the following table:
         
Gross proceeds
    $ 316,250,000  
Less:
         
Proceeds allocated to Public Warrants
    $ (12,036,716 ) 
Class A common stock issuance costs
      (17,177,930 ) 
Plus:
         
Accretion of carrying value to redemption value
    $ 33,958,396  
    
 
 
  
Class A common stock subject to possible redemption
    $ 320,993,750  
    
 
 
  
Offering Costs
Offering costs consisted of legal, accounting and other expenses incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs allocated to warrant liabilities were expensed as incurred in the statements of operations. Offering costs associated with the common stock subject to redemption issued were initially charged to temporary equity and then accreted up to redemption value against 
stockholders’ equity
upon the completion of the Initial Public Offering. Offering costs amounting to $17,177,930 were charged to temporary equity upon the completion of the Initial Public Offering, and $696,870 of the offering costs were related to the warrant liabilities and charged to the statements of operations.

 
F-11
Table of Contents
 
Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC 480 and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common stock and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.
For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional
paid-in
capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a
non-cash
gain or loss on the statements of operations.
The fair value of the warrants issued in the Initial Public Offering has been estimated using a Monte Carlo simulation methodology as of the date of the Initial Public Offering and such warrants quoted market price as of December 31, 2021 (see Note 10).
Income Taxes
The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021, and 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. The Company has two classes of common stock, which are referred to as Class A common stock and Class B common stock. Income and losses are shared pro rata between the two classes of common stock. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value.
The calculation of diluted income (loss) per common share does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 28,631,250 shares of Class A common stock in the aggregate. As of December 31, 2021, and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common shares is the same as basic net income (loss) per common share for the periods presented.
 
F-12
Table of Contents
The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts):
                                 
    
Year Ended

December 31, 2021
     
For the Period from July 30,

2020 (Inception) through

December 31, 2020
  
                             
    
Class A
     
Class B
     
Class A
     
Class B
  
                             
Basic and diluted net loss per common stock
                                    
Numerator:
                                    
Allocation of net loss, as adjusted
    $ (3,604,478 )     $ (901,119 )     $ (617,246 )     $ (1,120,152 ) 
Denominator:
                                    
Basic and diluted weighted average shares outstanding
      31,625,000        7,906,250        4,317,500        7,835,208  
    
 
 
     
 
 
     
 
 
     
 
 
  
Basic and diluted net loss per common stock
    $ (0.11 )     $ (0.11 )     $ (0.14 )     $ (0.14 ) 
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation coverage
limit
of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximate the carrying amounts represented in the accompanying consolidated balance sheets, primarily due to their short-term nature, except for the warrant liabilities (see Note 10).
Recent Accounting Standards
In August 2020, the FASB issued Accounting Standards Update
No.2020-06,
“Debt—Debt with Conversion and Other Options (Subtopic
470-20)”
and “Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40):
Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU
2020-06”),
which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU
2020-06
removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU
2020-06
is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company adopted ASU
2020-06
effective as of January 1, 2021. The adoption of ASU
2020-06
did not have an impact on the Company’s financial statements.
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial statements.
NOTE 3. INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 27,500,000 Units at a price of $10.00 per Unit. On December 14, 2020, the underwriters fully exercised their over-allotment option, resulting in an additional 4,125,000 Units issued for an aggregate amount of $41,250,000. Each Unit consists of one share of Class A common stock and
one-half
of one redeemable warrant (“
Public Warrant
”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).
 
F-13
Table of Contents
 
NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor and Jefferies purchased an aggregate of 11,375,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant from the Company, of which 10,000,000 Private Placement Warrants were purchased by the Sponsor and 1,375,000 Private Placement Warrants were purchased by Jefferies, in a private placement. On December 14, 2020, as a result of the underwriters’ election to fully exercise their over-allotment option, the Sponsor purchased an additional 1,269,231 Private Placement Warrants and Jeffries purchased an additional 174,519 Private Placement Warrants for a total of 1,443,750 Private Placement Warrants, at a price of $1.00 per Private Placement Warrants, or $1,443,750 in the aggregate. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8). The proceeds from the sale of the Private Placement Warrants were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.
NOTE 5. RELATED PARTY TRANSACTIONS
Founder Shares
On August 3, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 8,625,000 shares of Class B common stock (the “Founder Shares”). In November 2020, the Sponsor returned to the Company, at no cost, an aggregate of 1,437,500 Founder Shares, which the Company cancelled. In December 2020, the Company effected a stock dividend of 0.1 shares for each Founder Share outstanding, resulting in an aggregate of 7,906,250 Founder Shares issued and outstanding.
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Administrative Support Agreement
The Company has agreed, commencing on December 7, 2020, to pay the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. Upon completion of our initial Business Combination or our liquidation, the Company will cease paying these monthly fees. For the year ended December 31, 2021, and for the period from July 30, 2020 (inception) through December 31, 2020, the Company incurred $120,000 and $10,000 in fees for these services, respectively. As of December 31, 2021, and 2020, there was $130,000 and $10,000 of such fees included in accrued expenses, respectively.
Advances from Related Party
During 2021, the Sponsors advanced the Company an aggregate of $33,816 to fund operating expenses. The advances are non-interest bearing and payable upon demand. As of December 31, 2021, the amount advanced was repaid in full.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of the notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.
 
F-14
Table of Contents
On November 22, 2021, the Company issued an unsecured convertible promissory note (the “
Sponsor Convertible Note
”) to the Sponsor, pursuant to which the Company may borrow up to $2,000,000 from the Sponsor for ongoing expenses reasonably related to the business of the Company and the consummation of the Business Combination. All unpaid principal under the Sponsor Convertible Note will be due and payable in full on the earlier of (i) September 10, 2022, and (ii) the consummation of a Business Combination (such earlier date, the “Maturity Date”). The Sponsor will have the option, at any time on or prior to the Maturity Date, to convert up to $1,500,000 outstanding under the Sponsor Convertible Note into warrants to purchase shares of the Company’s Class A common stock, at a conversion price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.
As of December 31, 2021, there was $1,000,000 borrowings outstanding under the Convertible Notes
.
NOTE 6. COMMITMENTS
Risks and Uncertainties
Management continues to evaluate the impact of both the
COVID-19
pandemic and the Russian and Ukraine conflict and has concluded that while it is reasonably possible that the virus and the sanctions against Russian Federation and Belarus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Registration and Stockholder Rights
Pursuant to a registration rights agreement entered into on December 7, 2020, the holders of the Founder Shares, Private Placement Warrants and securities that may be issued upon conversion of Working Capital Loans will be entitled to registration rights require the Company to register a sale of any of the securities held by them pursuant to a registration rights agreement. The holders of the majority of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have certain “piggy-back” registration rights to include their securities in other registration statements filed by the Company, subject to certain limitations. Notwithstanding the foregoing, Jefferies may not exercise its demand and “piggyback” registration rights after five (5) and seven (7) years, respectively, after the Initial Public Offering and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $11,068,750 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
NOTE 7. STOCKHOLDERS’ DEFICIT
Preferred Stock
 — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2021 and 2020, there were no shares of preferred stock issued or outstanding.
Class
 A Common Stock
 — The Company is authorized to issue 100,000,000 shares of Class A common stock with a par value of $0.0001 per share. Holders of Class A common stock are entitled to one vote for each share. At December 31, 2021 and 2020, there were 31,625,000 shares of Class A common stock issued and outstanding, which are subject to possible redemption and presented as temporary equity.
F-15
Table of Contents
 
Class
 B Common Stock
 —
 
The Company is authorized to issue 10,000,000 shares of Class B common stock with a par value of $0.0001 per share. Holders of Class B common stock are entitled to one vote for each share. At December 31, 2021 and 2020, there were 7,906,250 shares of Class B common stock issued and outstanding.
Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as otherwise required by law.
The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination on a
one-for-one
basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in connection with a Business Combination, the number of shares of Class A common stock issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted basis,
20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering, plus the total number of shares of Class A common stock issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, including pursuant to a specified future issuance, excluding any shares of Class A common stock or equity-linked securities exercisable for or convertible into shares of Class A common stock issued, or to be issued, to any seller in a Business Combination and any private placement-equivalent warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one for one basis.
NOTE 8. WARRANT LIABILITIES
As of December 31, 2021, and 2020, there were 15,812,500 Public Warrants outstanding.
Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination and (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of Class A common stock underlying the warrants is then effective and a current prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable, and the Company will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of a Business Combination, it will use its best efforts to file with the SEC a registration statement registering the issuance of the shares of Class A common stock issuable upon exercise of the warrants, to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60
th
business day after the closing of a Business Combination or within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” pursuant to the exemption provided by Section 3(a)(9) of the Securities Act; provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.
 
F-16
Redemptions of warrants when the price of Class
 A common stock equals or exceeds $18.00
— Once the warrants become exercisable, the Company may redeem the Public Warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon not less than 30 days’ prior written notice of redemption, or the
30-day
redemption period, to each warrant holder; and
 
  •  
if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a
30-trading
day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or its affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A common stock during the 20 trading day period starting on the trading day after the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.
As of December 31, 2021, and 2020, there were 12,818,750 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or saleable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be
non-redeemable,
except as described above, so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.
 
F-17
Table of Contents
 
NOTE 9. INCOME TAX

The Company’s net deferred tax assets are as follows:
                 
    
December 31,
2021
     
For the
Period from

July 30, 2020

(Inception)
through
December 31,
2020
  
Deferred tax asset
                  
Net operating loss carryforward
    $ 42,728      $ 16,030  
Organizational costs/Startup expenses
      1,442,151        5,494  
    
 
 
     
 
 
  
Total deferred tax assets
      1,484,879        21,524  
Valuation allowance
      (1,484,879 )       (21,524 ) 
    
 
 
     
 
 
  
Deferred tax assets, net of allowance
    $ —        $ —    
    
 
 
     
 
 
  
The income tax provision consists of the following:
                 
    
December 31,
2021
     
For the
Period from

July 30, 2020

(Inception)
through
December 31,
2020
  
Federal
                  
Current
    $ —        $ —    
Deferred
      (1,463,355 )       (21,524 ) 
State
                  
Current
    $ —        $ —    
Deferred
      —          —    
Change in valuation allowance
      1,463,355        21,524  
    
 
 
     
 
 
  
Income tax provision
    $ —        $ —    
    
 
 
     
 
 
  
As of December 31, 2021, and 2020, the Company had $203,467
and $76,333 
of U.S. federal and state net operating loss carryovers available to offset future taxable income, respectively.
In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the consummation of a Business Combination and the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the year ended December 31, 2021, and for the period from July 30, 2020 (inception) through December 31, 2020, the change in the valuation allowance was $1,463,355 and $21,524, respectively.
 
F-18
Table of Contents
A reconciliation of the federal income tax rate to the Company’s effective tax rate for the year ended December 31, 2021, and for the period from July 30, 2020 (inception) through December 31, 2020
,
is as follows:
                 
    
December 31,
2021
    
For the Period

from July 30,

2020
(Inception)
through
December 31,
2020
  
              
Statutory federal income tax rate
      21.0 %      21.0 % 
State taxes, net of federal tax benefit
      0.0 %      0.0 % 
Change in fair value of warrants
      11.5 %      (11.3 )% 
Transaction costs
      0.0 %      (8.4 )% 
Change in valuation allowance
      (32.5 )%      (1.2 )% 
    
 
 
    
 
 
  
Income tax provision
      0.0 %      0.0 % 
    
 
 
    
 
 
  
The Company files income tax returns in the U.S. federal jurisdiction in various state and local jurisdictions and is subject to examination by the various taxing authorities.
NOTE 10. FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
Level 1:    Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:    Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:    Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
The Company classifies its U.S. Treasury and equivalent securities as
held-to-maturity
in accordance with ASC Topic 320 “Investments—Debt and Equity Securities.”
Held-to-maturity
securities are those securities which the Company has the ability and intent to hold until maturity.
Held-to-maturity
treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts.
At December 31, 2021, assets held in the Trust Account were comprised of $321,039,924 money market funds that primarily invest in U.S. Treasury securities at fair market value. For the year ended December 31, 2021, the Company withdrew $35,108 of interest income from the Trust Account to pay franchise and income taxes.
At December 31, 2020, assets held in the Trust Account were comprised of $425 in cash and $321,001,741 in U.S. Treasury securities. During the period from July 30, 2020 (inception) to December 31, 2020, the Company did not withdraw any interest income from the Trust Account.
 
F-19
Table of Contents
 
    
Description
   
Level
     
Amortized

Cost
     
Gross

Holding

Loss
     
Fair Value
  
December 31, 2020
   
Assets
:		                                    
    
Held-to-Maturity
Investments—U.S. Treasury Securities (Matured on 3/11/2021)		      1      $ 321,001,741      $ (18,297 )     $ 320,983,444  
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2021 and 2020 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
                         
Description
   
Level
     
December 31,

2021
     
December 31,

2020
  
                      
Assets:
                           
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund
      1      $ 321,039,924      $ —    
Liabilities:
                           
Warrant Liability – Public Warrants
      1      $ 12,175,625      $ 12,573,343  
Warrant Liability – Private Placement Warrants
      3      $ 9,921,713      $ 11,986,758  
The Warrants were accounted for as liabilities in accordance with ASC
815-40
and are presented within warrant liabilities the accompanying consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statements of operations.
The Private Placement Warrants were initially and continue to be valued using a Modified Black Scholes Option Pricing Model, which is considered to be a Level 3 fair value measurement. The Modified Black Scholes model’s primary unobservable input utilized in determining the fair value of the Private Placement Warrants is the expected volatility of the common stock. The expected volatility as of the Initial Public Offering date was derived from observable public warrant pricing on comparable ‘blank-check’ companies without an identified target. The expected volatility as of subsequent valuation dates was implied from the Company’s own public warrant pricing. A Monte Carlo simulation methodology was used in estimating the fair value of the Public Warrants for periods where no observable traded price was available, using the same expected volatility as was used in measuring the fair value of the Private Placement Warrants. For periods subsequent to the detachment of the Public Warrants from the Units, the close price of the Public Warrant price was used as the fair value as of each relevant date.
The following table provides quantitative information regarding Level 3 fair value measurements:
                 
    
December 31,

2021
    
December 31,

2020
  
Stock price
    $ 9.94     $ 6.87  
Strike price
    $ 11.50     $ 11.50  
Term (in years)
      4.30       5.0  
Volatility
      14.1 %      40.0 % 
Risk-free rate
      1.16 %      0.57 % 
Dividend yield
      0.0 %      0.0 % 
 
F-20
 
The following table presents the changes in the fair value of Level 3 warrant liabilities:

 
  
Private Placement
 
Fair value as of July 30, 2020 (inception)
  
$
—  
 
Initial measurement on December 10, 2020
  
 
11,585,352
 
Change in valuation inputs or other assumptions
  
 
401,406
 
Fair value as of December 31, 2020
  
 
11,986,758
 
 
 
 
 
 
Change in fair value
  
 
(2,065,045
) 
  
 
 
 
Fair value as of December 31, 2021
  
$
9,921,713
 
  
 
 
Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels for the year ended December 31, 2021, and for the period from July 30, 2020 (inception) through December 31, 2020.
NOTE 11. SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the consolidated financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated
financial statements.
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements. The specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
 
F-21
Table of Contents
EXHIBIT INDEX
 
Exhibit No.
   
Description
    1.1    Underwriting Agreement dated January 7, 2021 between the Company and Jefferies LLC (2)
    3.1    Amended and Restated Certificate of Incorporation (2)
    3.2    Bylaws (1)
    4.1    Specimen Unit Certificate (1)
    4.2    Specimen Class A Common Stock Certificate (1)
    4.3    Specimen Warrant Certificate (1)
    4.4    Warrant Agreement dated December 7, 2020 by and between the Company and Continental Stock Transfer & Trust Company (2)
    4.5    Description of Registered Securities (3)
  10.1    Letter Agreement dated December 7, 2020 by and among the Company, Mudrick Capital Acquisition Holdings II LLC and each of the directors and executive officers of the Company (2)
  10.2    Investment Management Trust Agreement dated December 7, 2020 by and between Continental Stock Transfer & Trust Company and the Company (2)
  10.3    Promissory Note issued to Mudrick Capital Acquisition Holdings II LLC (1)
  10.4    Registration Rights Agreement dated December 7, 2020 by and among the Company, Mudrick Capital Acquisition Holdings II LLC and the Holders signatory thereto (2)
  10.5    Private Placement Warrant Purchase Agreement dated December 7, 2020 by and between the Company and Mudrick Capital Acquisition Holdings II LLC (4)
  10.6    Private Placement Warrant Purchase Agreement dated December 7, 2020 by and between the Company and Jefferies LLC (2)
  10.7    Administrative Support Agreement dated December 7, 2020 by and between the Company and Mudrick Capital Acquisition Holdings II LLC (2)
  10.8    Form of Indemnity Agreement (1)
  10.9    Promissory Note issued to Mudrick Capital Acquisition Holdings II LLC (5)
31.1*    Certification of the Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
31.2*    Certification of the Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
32.1**    Certification of the Principal Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2**    Certification of the Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
101.INS    Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101.SCH    Inline XBRL Taxonomy Extension Schema
101.CAL    Inline XBRL Taxonomy Calculation Linkbase
101.LAB    Inline XBRL Taxonomy Label Linkbase
101.PRE    Inline XBRL Definition Linkbase Document
101.DEF    Inline XBRL Definition Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*
Filed herewith.
**
Furnished herewith.
(1)
Incorporated by reference to the Company’s Form
S-1,
originally filed with the SEC on October 9, 2020 (File
No. 333-249402)
and as thereafter amended.
(2)
Incorporated by reference to the Company’s Form
8-K,
filed with the SEC on December 11, 2020.
(3)
Incorporated by reference to the Company’s Form
10-K,
filed with the SEC on April 2, 2021.
(4)
Incorporated by reference to the Company’s Form
10-K/A,
filed with the SEC on April 6, 2021.
(5)
Incorporated by reference to the Company’s
Form 8-K,
filed with the SEC on November 24, 2021.
Table of Contents
SIGNATURES
Pursuant to the requirements of Section13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
March 31, 2022    
MUDRICK CAPITAL ACQUISITION CORPORATION II
    By:  
/s/ Jason Mudrick
    Name:   Jason Mudrick
    Title:   Chief Executive Officer (Principal Executive Officer)
EX-31.1

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Jason Mudrick, certify that:

1. I have reviewed this Annual Report on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A, of Mudrick Capital Acquisition Corp. II.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: March 31, 2022   

/s/ Jason Mudrick

   Jason Mudrick
   Chief Executive Officer
   (Principal Executive Officer)
EX-31.2

Exhibit 31.2

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Glenn Springer, certify that:

1. I have reviewed this Annual Report on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A, of Mudrick Capital Acquisition Corp. II.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statement made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: March 31, 2022

 

/s/ Glenn Springer

 

Glenn Springer

Chief Financial Officer
(Principal Financial and Accounting Officer)
EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Mudrick Capital Acquisition Corp. II (the “Registrant”) on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A, for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

This certificate is being furnished solely for the purposes of 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

Date: March 31, 2022

 

/s/ Jason Mudrick

 

Jason Mudrick

Chief Executive Officer

(Principal Executive Officer)

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Mudrick Capital Acquisition Corp. II (the “Registrant”) on Form 10-K, as amended by Amendment No. 1 on Form 10-K/A, for the year ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

This certificate is being furnished solely for the purposes of 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate disclosure document.

Date: March 31, 2022

 

/s/ Glenn Springer

 

Glenn Springer

Chief Financial Officer
(Principal Financial and Accounting Officer)